Lauren L Drogos1, Stephanie J Gill1, Amanda V Tyndall1, Jill K Raneri1, Jillian S Parboosingh1, Aileen Naef1, Kyle D Guild1, Gail Eskes1, Patrick J Hanly1, Marc J Poulin2. 1. From the Department of Physiology & Pharmacology (L.L.D., A.V.T., A.N., K.D.G., G.E., M.J.P.), Hotchkiss Brain Institute (L.L.D., S.J.G., A.V.T., A.N., K.D.G., P.J.H., M.J.P.), Department of Medical Sciences (S.J.G.), Department of Medicine (J.K.R., P.J.H.), Department of Medical Genetics (J.S.P.), Department of Clinical Neurosciences (M.J.P.), and Libin Cardiovascular Institute of Alberta (M.J.P.), Cumming School of Medicine, and Alberta Children's Hospital Research Institute for Child and Maternal Health (J.S.P.), Faculty of Kinesiology (M.J.P.), and Sleep Centre, Foothills Medical Centre (J.K.R., P.J.H.), University of Calgary; and Department of Psychiatry, Faculty of Medicine (G.E.), and Department of Psychology and Neuroscience, Faculty of Science (G.E.), Dalhousie University, Halifax, Canada. 2. From the Department of Physiology & Pharmacology (L.L.D., A.V.T., A.N., K.D.G., G.E., M.J.P.), Hotchkiss Brain Institute (L.L.D., S.J.G., A.V.T., A.N., K.D.G., P.J.H., M.J.P.), Department of Medical Sciences (S.J.G.), Department of Medicine (J.K.R., P.J.H.), Department of Medical Genetics (J.S.P.), Department of Clinical Neurosciences (M.J.P.), and Libin Cardiovascular Institute of Alberta (M.J.P.), Cumming School of Medicine, and Alberta Children's Hospital Research Institute for Child and Maternal Health (J.S.P.), Faculty of Kinesiology (M.J.P.), and Sleep Centre, Foothills Medical Centre (J.K.R., P.J.H.), University of Calgary; and Department of Psychiatry, Faculty of Medicine (G.E.), and Department of Psychology and Neuroscience, Faculty of Science (G.E.), Dalhousie University, Halifax, Canada. poulin@ucalgary.ca.
Abstract
BACKGROUND: It has been estimated that the prevalence of Alzheimer disease (AD) and related dementias will triple by 2035, unless effective interventions or treatments are found for the neurodegenerative disease. Understanding sleep changes as a marker for both AD risk and progression is a burgeoning area of investigation. Specifically, there is emerging evidence that both sleep disturbances and the APOE ε4 allele are associated with increased dementia risk. Previous research has suggested that in AD, individuals carrying the APOE ε4 allele have decreased sleep quality compared to individuals without the APOE ε4 allele. This observational trial aimed to determine if healthy older adults with the risk allele (APOE ε4+) have more sleep complaints or evidence of objective sleep disruption compared to healthy older adults without the risk allele (APOE ε4-). METHODS: Within the larger Brain in Motion study, a subset of participants completed at-home polysomnography (PSG) and actigraphy sleep assessment. Subjective sleep complaints were determined using the Pittsburgh Sleep Quality Index. RESULTS: This investigation found a significant relationship between presence of APOE ε4 allele and objective sleep disturbances measured by both actigraphy and PSG, but not subjective sleep complaints in a healthy population screened for dementia. CONCLUSIONS: These data suggest that the influence of APOE ε4 allele on objective sleep quality may precede subjective sleep complaints in individuals at increased risk for dementia.
BACKGROUND: It has been estimated that the prevalence of Alzheimer disease (AD) and related dementias will triple by 2035, unless effective interventions or treatments are found for the neurodegenerative disease. Understanding sleep changes as a marker for both AD risk and progression is a burgeoning area of investigation. Specifically, there is emerging evidence that both sleep disturbances and the APOE ε4 allele are associated with increased dementia risk. Previous research has suggested that in AD, individuals carrying the APOE ε4 allele have decreased sleep quality compared to individuals without the APOE ε4 allele. This observational trial aimed to determine if healthy older adults with the risk allele (APOE ε4+) have more sleep complaints or evidence of objective sleep disruption compared to healthy older adults without the risk allele (APOE ε4-). METHODS: Within the larger Brain in Motion study, a subset of participants completed at-home polysomnography (PSG) and actigraphy sleep assessment. Subjective sleep complaints were determined using the Pittsburgh Sleep Quality Index. RESULTS: This investigation found a significant relationship between presence of APOE ε4 allele and objective sleep disturbances measured by both actigraphy and PSG, but not subjective sleep complaints in a healthy population screened for dementia. CONCLUSIONS: These data suggest that the influence of APOE ε4 allele on objective sleep quality may precede subjective sleep complaints in individuals at increased risk for dementia.
Authors: Yo-El S Ju; Jennifer S McLeland; Cristina D Toedebusch; Chengjie Xiong; Anne M Fagan; Stephen P Duntley; John C Morris; David M Holtzman Journal: JAMA Neurol Date: 2013-05 Impact factor: 18.302
Authors: Daniel J Buysse; Martica L Hall; Patrick J Strollo; Thomas W Kamarck; Jane Owens; Laisze Lee; Steven E Reis; Karen A Matthews Journal: J Clin Sleep Med Date: 2008-12-15 Impact factor: 4.062
Authors: Andrew S P Lim; Lei Yu; Matthew Kowgier; Julie A Schneider; Aron S Buchman; David A Bennett Journal: JAMA Neurol Date: 2013-12 Impact factor: 18.302
Authors: Cristina D Toedebusch; Jennifer S McLeland; Claire M Schaibley; Ian R Banks; Jill Boyd; John C Morris; David M Holtzman; Brendan P Lucey Journal: J Vis Exp Date: 2019-01-26 Impact factor: 1.355
Authors: Adam P Spira; Yang An; Yu Peng; Mark N Wu; Eleanor M Simonsick; Luigi Ferrucci; Susan M Resnick Journal: Sleep Date: 2017-08-01 Impact factor: 5.849
Authors: Alice Taubes; Phil Nova; Kelly A Zalocusky; Idit Kosti; Mesude Bicak; Misha Y Zilberter; Yanxia Hao; Seo Yeon Yoon; Tomiko Oskotsky; Silvia Pineda; Bin Chen; Emily A Aery Jones; Krishna Choudhary; Brian Grone; Maureen E Balestra; Fayzan Chaudhry; Ishan Paranjpe; Jessica De Freitas; Nicole Koutsodendris; Nuo Chen; Celine Wang; William Chang; Alice An; Benjamin S Glicksberg; Marina Sirota; Yadong Huang Journal: Nat Aging Date: 2021-10-11
Authors: Jaimie C Hunter; Elizabeth P Handing; Ramon Casanova; Maragatha Kuchibhatla; Michael W Lutz; Santiago Saldana; Brenda L Plassman; Kathleen M Hayden Journal: Alzheimers Dement Date: 2018-02-01 Impact factor: 21.566
Authors: Matiram Pun; Sara E Hartmann; Michael Furian; Adrienna M Dyck; Lara Muralt; Mona Lichtblau; Patrick R Bader; Jean M Rawling; Silvia Ulrich; Konrad E Bloch; Marc J Poulin Journal: Front Physiol Date: 2018-06-04 Impact factor: 4.566
Authors: Andrée-Ann Baril; Alexa S Beiser; Erlan Sanchez; Vincent Mysliwiec; Susan Redline; Daniel J Gottlieb; George T O'Connor; Mitzi M Gonzales; Dibya Himali; Sudha Seshadri; Jayandra J Himali; Matthew P Pase Journal: Alzheimers Dement Date: 2021-07-26 Impact factor: 16.655